Conference Reports for NATAP

22nd Conference on Retroviruses and Opportunistic Infections Seattle Washington Feb 23 - 26, 2015 Back

Drug Interactions Between the anti-HCV Regimen Ledipasvir/Sofosbuvir and Ritonavir Boosted Protease Inhibitors plus Emtricitabine/Tenofovir DF       webcast: http://www.croiwebcasts.org/console/player/25669?mediaType=slideVideo&   Reported by Jules Levin CROI 2015 Feb 23-26 Seattle, WA